×

Method for treating amyloid disease

  • US 8,906,382 B2
  • Filed: 07/19/2012
  • Issued: 12/09/2014
  • Est. Priority Date: 07/19/2011
  • Status: Active Grant
First Claim
Patent Images

1. A polymerized form of an immunogenic modified Aβ

  • peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ

    1-42, which polymerized form is soluble, non-fibrillogenic, has molecular weight less than 100 kDa, has the property of eliciting antibodies directed against the abnormal conformation of Aβ

    in amyloid plaques and/or in soluble and semi-soluble Aβ

    oligomers, and is produced using controlled polymerization of peptide monomers with glutaraldehyde.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×